The effects of tirzepatide on body weight control have also been confirmed in non-diabetic individuals in the SURMOUNT-1 study, where treatment with tirzepatide 1015 mg was associated with an average weight loss of approximately 20% at 72 weeks, exceeding 25% in one third of the patients
Three weeks post TM induction, the pancreata were collected for experiments
Beyond glycaemic control, Rybelsus offers additional cardiometabolic benefits
Polymeric nanoparticles, especially those derived from PLGA (poly(lactic-co-glycolic acid)), have been used to prepare long-acting formulations of GLP-1 that can extend the release period to weeks with a single dose, reducing injection frequency and improving patient adherence [33]
In addition, L-carnitine reduced neuroinflammation evidenced by its effect on p65 NF-B and the underlying cytokines: IL-1 and TNF-